- Report
- August 2024
- 214 Pages
China
From €3610EUR$4,000USD£3,136GBP
- Report
- March 2024
- 132 Pages
Global
From €857EUR$950USD£745GBP
- Report
- March 2024
- 132 Pages
Global
From €857EUR$950USD£745GBP
- Report
- March 2024
- 132 Pages
Global
From €857EUR$950USD£745GBP
- Report
- March 2024
- 132 Pages
Global
From €857EUR$950USD£745GBP
- Report
- June 2023
- 132 Pages
Global
From €857EUR$950USD£745GBP
- Book
- January 2020
North America

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more